310 related articles for article (PubMed ID: 35710078)
1. Fyn-kinase and caveolin-1 in the alveolar epithelial junctional adherence complex contribute to the early stages of pulmonary fibrosis.
Menzel V; Ziegler M; Hante N; Sake JA; Santos-Martinez MJ; Ehrhardt C; Kasper M; Barth K
Eur J Pharm Sci; 2022 Aug; 175():106236. PubMed ID: 35710078
[TBL] [Abstract][Full Text] [Related]
2. Differential effects of Nintedanib and Pirfenidone on lung alveolar epithelial cell function in ex vivo murine and human lung tissue cultures of pulmonary fibrosis.
Lehmann M; Buhl L; Alsafadi HN; Klee S; Hermann S; Mutze K; Ota C; Lindner M; Behr J; Hilgendorff A; Wagner DE; Königshoff M
Respir Res; 2018 Sep; 19(1):175. PubMed ID: 30219058
[TBL] [Abstract][Full Text] [Related]
3. Caveolin-1 deficiency protects from pulmonary fibrosis by modulating epithelial cell senescence in mice.
Shivshankar P; Brampton C; Miyasato S; Kasper M; Thannickal VJ; Le Saux CJ
Am J Respir Cell Mol Biol; 2012 Jul; 47(1):28-36. PubMed ID: 22362388
[TBL] [Abstract][Full Text] [Related]
4. MAP3K19 Is a Novel Regulator of TGF-β Signaling That Impacts Bleomycin-Induced Lung Injury and Pulmonary Fibrosis.
Boehme SA; Franz-Bacon K; DiTirro DN; Ly TW; Bacon KB
PLoS One; 2016; 11(5):e0154874. PubMed ID: 27144281
[TBL] [Abstract][Full Text] [Related]
5. Caveolin-1 gene therapy inhibits inflammasome activation to protect from bleomycin-induced pulmonary fibrosis.
Lin X; Barravecchia M; Matthew Kottmann R; Sime P; Dean DA
Sci Rep; 2019 Dec; 9(1):19643. PubMed ID: 31873099
[TBL] [Abstract][Full Text] [Related]
6. Syndecan-2 exerts antifibrotic effects by promoting caveolin-1-mediated transforming growth factor-β receptor I internalization and inhibiting transforming growth factor-β1 signaling.
Shi Y; Gochuico BR; Yu G; Tang X; Osorio JC; Fernandez IE; Risquez CF; Patel AS; Shi Y; Wathelet MG; Goodwin AJ; Haspel JA; Ryter SW; Billings EM; Kaminski N; Morse D; Rosas IO
Am J Respir Crit Care Med; 2013 Oct; 188(7):831-41. PubMed ID: 23924348
[TBL] [Abstract][Full Text] [Related]
7. Caveolin-1-derived peptide limits development of pulmonary fibrosis.
Marudamuthu AS; Bhandary YP; Fan L; Radhakrishnan V; MacKenzie B; Maier E; Shetty SK; Nagaraja MR; Gopu V; Tiwari N; Zhang Y; Watts AB; Williams RO; Criner GJ; Bolla S; Marchetti N; Idell S; Shetty S
Sci Transl Med; 2019 Dec; 11(522):. PubMed ID: 31826982
[TBL] [Abstract][Full Text] [Related]
8. Profibrotic epithelial TGF-β1 signaling involves NOX4-mitochondria cross talk and redox-mediated activation of the tyrosine kinase FYN.
Veith C; Hristova M; Danyal K; Habibovic A; Dustin CM; McDonough JE; Vanaudenaerde BM; Kreuter M; Schneider MA; Kahn N; van Schooten FJ; Boots AW; van der Vliet A
Am J Physiol Lung Cell Mol Physiol; 2021 Mar; 320(3):L356-L367. PubMed ID: 33325804
[TBL] [Abstract][Full Text] [Related]
9. The MIR100HG/miR-29a-3p/Tab1 axis modulates TGF-β1-induced fibrotic changes in type II alveolar epithelial cells BLM-caused lung fibrogenesis in mice.
Guan S; Liu H; Zhou J; Zhang Q; Bi H
Toxicol Lett; 2022 Jun; 363():45-54. PubMed ID: 35472619
[TBL] [Abstract][Full Text] [Related]
10. Fluorofenidone attenuates bleomycin-induced pulmonary inflammation and fibrosis in mice via restoring caveolin 1 expression and inhibiting mitogen-activated protein kinase signaling pathway.
Meng J; Zou Y; Hu C; Zhu Y; Peng Z; Hu G; Wang Z; Tao L
Shock; 2012 Nov; 38(5):567-73. PubMed ID: 23042199
[TBL] [Abstract][Full Text] [Related]
11. Effects and mechanisms of pirfenidone, prednisone and acetylcysteine on pulmonary fibrosis in rat idiopathic pulmonary fibrosis models.
Yu W; Guo F; Song X
Pharm Biol; 2017 Dec; 55(1):450-455. PubMed ID: 27937011
[TBL] [Abstract][Full Text] [Related]
12. CSF3 aggravates acute exacerbation of pulmonary fibrosis by disrupting alveolar epithelial barrier integrity.
Guo B; Liu W; Ji X; Xi B; Meng X; Xie W; Sun Y; Zhang M; Liu P; Zhang W; Yan X; Chen B
Int Immunopharmacol; 2024 Jun; 135():112322. PubMed ID: 38788452
[TBL] [Abstract][Full Text] [Related]
13. Caveolin-1: a critical regulator of lung fibrosis in idiopathic pulmonary fibrosis.
Wang XM; Zhang Y; Kim HP; Zhou Z; Feghali-Bostwick CA; Liu F; Ifedigbo E; Xu X; Oury TD; Kaminski N; Choi AM
J Exp Med; 2006 Dec; 203(13):2895-906. PubMed ID: 17178917
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of permeability alteration and epithelial-mesenchymal transition induced by transforming growth factor-β
Togami K; Yamaguchi K; Chono S; Tada H
J Pharmacol Toxicol Methods; 2017 Jul; 86():19-27. PubMed ID: 28259823
[TBL] [Abstract][Full Text] [Related]
15. Atractylodin Suppresses TGF-β-Mediated Epithelial-Mesenchymal Transition in Alveolar Epithelial Cells and Attenuates Bleomycin-Induced Pulmonary Fibrosis in Mice.
Chang KW; Zhang X; Lin SC; Lin YC; Li CH; Akhrymuk I; Lin SH; Lin CC
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681813
[TBL] [Abstract][Full Text] [Related]
16. Antifibrotic mechanism of avitinib in bleomycin-induced pulmonary fibrosis in mice.
Miao Y; Wang Y; Bi Z; Huang K; Gao J; Li X; Li S; Wei L; Zhou H; Yang C
BMC Pulm Med; 2023 Mar; 23(1):94. PubMed ID: 36949426
[TBL] [Abstract][Full Text] [Related]
17.
Borok Z; Horie M; Flodby P; Wang H; Liu Y; Ganesh S; Firth AL; Minoo P; Li C; Beers MF; Lee AS; Zhou B
Am J Respir Crit Care Med; 2020 Jan; 201(2):198-211. PubMed ID: 31738079
[No Abstract] [Full Text] [Related]
18. MiR-326-mediated overexpression of NFIB offsets TGF-β induced epithelial to mesenchymal transition and reverses lung fibrosis.
Pattnaik B; Negi V; Chaudhuri R; Desiraju K; Faizan MI; Akhtar A; Ansari MS; Shakir M; Gheware A; Prakash YS; Guleria R; Ghosh B; Agrawal A; Ahmad T
Cell Mol Life Sci; 2023 Nov; 80(12):357. PubMed ID: 37950757
[TBL] [Abstract][Full Text] [Related]
19. The Anti-fibrotic and Anti-inflammatory Potential of Bone Marrow-Derived Mesenchymal Stem Cells and Nintedanib in Bleomycin-Induced Lung Fibrosis in Rats.
Gad ES; Salama AAA; El-Shafie MF; Arafa HMM; Abdelsalam RM; Khattab M
Inflammation; 2020 Feb; 43(1):123-134. PubMed ID: 31646446
[TBL] [Abstract][Full Text] [Related]
20. Protein tyrosine phosphatase-α amplifies transforming growth factor-β-dependent profibrotic signaling in lung fibroblasts.
Aschner Y; Nelson M; Brenner M; Roybal H; Beke K; Meador C; Foster D; Correll KA; Reynolds PR; Anderson K; Redente EF; Matsuda J; Riches DWH; Groshong SD; Pozzi A; Sap J; Wang Q; Rajshankar D; McCulloch CAG; Zemans RL; Downey GP
Am J Physiol Lung Cell Mol Physiol; 2020 Aug; 319(2):L294-L311. PubMed ID: 32491951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]